• Home
  • 40th Annual Meeting of the American Academy of Sleep Medicine

SLEEP 2026


Baltimore, MD

40th Annual Meeting of the American Academy of Sleep Medicine
Explore more Sleep congress materials
Material Type

Results(23)

Sleep
Improvements in Sleep Inertia With Low-Sodium Oxybate Treatment in Participants With Narcolepsy Type 1 and Type 2 in the DUET Study
Author(s): Deborah A. Nichols, MS, Logan D. Schneider, MD, David T. Plante, MD, PhD et al.
Improvements in Sleep Inertia With Low-Sodium Oxybate Treatment in Participants With Narcolepsy Type 1 and Type 2 in the DUET Study
Author(s): Deborah A. Nichols, MS, David T. Plante, MD, PhD, Logan D. Schneider, MD et al.
Effectiveness and Safety of Low-Sodium Oxybate by PatientReported Long Sleep Need in DUET Study Participants With Idiopathic Hypersomnia
Author(s): David T. Plante, MD, PhD, Chad M. Ruoff, MD, Logan D. Schneider, MD et al.
Individualized Dosing of LowSodium Oxybate in Patients With Narcolepsy or Idiopathic Hypersomnia
Author(s): Nancy Foldvary-Schaefer, DO, MS, Gerard J. Meskill, MD, Deborah A. Nichols, MS et al.
Nocturnal Sleep Features as a Candidate Mechanism for Improvements in Daytime Sleepiness and Disease Severity in Idiopathic Hypersomnia or Narcolepsy
Author(s): Alyssa Cairns, PhD, David T. Plante, MD, PhD, Chad M. Ruoff, MD et al.
Importance of Nocturnal Sleep Features for Disease-Specific Improvements in Idiopathic Hypersomnia or Narcolepsy
Author(s): Alyssa Cairns, PhD, David T. Plante, MD, PhD, Chad M. Ruoff, MD et al.
Improvements in Sleep Inertia With Low-Sodium Oxybate Treatment in Participants With Idiopathic Hypersomnia in the DUET Study
Author(s): Deborah A. Nichols, MS, Logan D. Schneider, MD, Chad M. Ruoff, MD et al.
Clinical Responders to Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia​
Author(s): Bart Sangal, MD, Chad M. Ruoff, MD, Deborah A. Nichols, MS et al.
Clinical Responders to Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia
Author(s): R. Bart Sangal, MD, Chad M. Ruoff, MD, Deborah A. Nichols, MS et al.
Changes in Cardiovascular and Cardiometabolic Biomarkers Following Low-Sodium Oxybate Initiation for Narcolepsy or Idiopathic Hypersomnia
Author(s): Sarah C. Markt, ScD, MPH, Jessica K. Alexander, PhD, Alejandro G. Hughes, MPH et al.
Estimating the Prevalence of Diagnosed Idiopathic Hypersomnia in the Pediatric Population: A US Claims Analysis
Author(s): Natalie Gavrielov-Yusim, PhD, Sarah C. Markt, ScD, MPH, Jerrod Nelms, PhD, MPH et al.
Individualized Dosing With Low-Sodium Oxybate in Idiopathic Hypersomnia: Patient Voices From LYRICAL
Author(s): Caroleen Drachenberg, PhD, MSPH, Meagan Farrell, PhD, Jennifer D’Souza, PhD, MPH et al.
Individualized Dosing With LowSodium Oxybate in Narcolepsy: Patient Voices From LYRICAL
Author(s): Caroleen Drachenberg, PhD, MSPH, Meagan Farrell, PhD, Jennifer D’Souza, PhD, MPH et al.
Effectiveness and Satisfaction WithLow-Sodium Oxybate as Described by Adults Living With Idiopathic Hypersomnia: LYRICAL Survey and Interview Findings
Author(s): Caroleen Drachenberg, PhD, MSPH, Meagan Farrell, PhD, Jennifer D’Souza, PhD, MPH et al.
Effectiveness and Satisfaction With Low-Sodium Oxybate as Described by Adults Living With Narcolepsy: LYRICAL Survey and Interview Findings
Author(s): Caroleen Drachenberg, PhD, MSPH, Meagan Farrell, PhD, Jennifer D’Souza, PhD, MPH et al.
Daytime and Nighttime Symptom Improvements Are Associated With Better Quality of Life in Idiopathic Hypersomnia: Findings From LYRICAL
Author(s): Caroleen Drachenberg, PhD, MSPH, Meagan Farrell, PhD, Jennifer D’Souza, PhD, MPH et al.
Improvements in Nighttime Sleep Quality and Daytime Sleepiness Are Associated With Better Quality of Life in Narcolepsy: Findings From LYRICAL
Author(s): Caroleen Drachenberg, PhD, MSPH, Meagan Farrell, PhD, Jennifer D’Souza, PhD, MPH et al.
A Conceptual Disease Model of the Symptoms and Impacts of Narcolepsy Type 1 From the Patient Perspective
Author(s): Cristina Casstevens, PhD, Nancy Foldvary-Schaefer, DO, MS, Kiran Maski, MD, MPH et al.
A Conceptual Disease Model of the Symptoms and Impacts of Narcolepsy Type 2 From the Patient Perspective
Author(s): Cristina Casstevens, PhD, Kiran Maski, MD, MPH, Nancy FoldvarySchaefer, DO, MS et al.
Clinically Relevant Symptoms of Narcolepsy and Idiopathic Hypersomnia in Patients Initiating Low-Sodium Oxybate: Electronic Health Record Notes Study
Author(s): Sarah C. Markt, ScD, MPH, Marisa Whalen, PharmD, Caroleen Drachenberg, PhD, MSPH et al.
Individualized Dosing and Drug Utilization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia: Results From Post-Marketing Data
Author(s): Natalie Gavrielov-Yusim, PhD, Jerrod Nelms, PhD, MPH, Jing Dai, PhD et al.
Patient-Reported Improvement in Hypersomnolence Measures in Participants With Narcolepsy Taking >9 Gram Dosage of Low-Sodium Oxybate in the DUET Study
Author(s): Richard K. Bogan, MD, Chad M. Ruoff, MD, David T. Plante, MD, PhD et al.
Changes in Patient-Reported Symptoms After Switching From High- to Low-Sodium Oxybate in Participants With Narcolepsy in the XYLO Study
Author(s): Virend K. Somers, MD, PhD, Yves Dauvilliers, MD, PhD, Deborah A. Nichols, MS et al.